Clinical Trial Update: An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports the long-term efficacy and safety results of risperidone microspheres in participants with schizophrenia and schizoaf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperidone microspheres (risperidone)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-08-09